Mucin fusion polypeptide vaccines, compositions and methods of use thereof

Details for Australian Patent Application No. 2003228067 (hide)

Owner Recopharma AB

Inventors Holgersson, Jan

Agent Cullen & Co

Pub. Number AU-B-2003228067

PCT Number PCT/IB03/02207

PCT Pub. Number WO2003/088995

Priority 60/375,095 22.04.02 US

Filing date 22 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 29 May 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/015 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/04 (2006.01) Medicinal preparations containing antigens or antibodies - Mycobacterium, e.g. Mycobacterium tuberculosis

A61K 39/118 (2006.01) Medicinal preparations containing antigens or antibodies - Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/145 (2006.01) Medicinal preparations containing antigens or antibodies - Orthomyxoviridae, e.g. influenza virus

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/245 (2006.01) Medicinal preparations containing antigens or antibodies - Herpetoviridae, e.g. herpes simplex virus

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61K 39/385 (2006.01) Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/00 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

C07K 14/025 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 19/00 (2006.01) Hybrid peptides

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

14 August 2003 Complete Application Filed

  Priority application(s): 60/375,095 22.04.02 US

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003228067

29 May 2008 Application Accepted

  Published as AU-B-2003228067

25 September 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003228068-CONTENT AUGMENTATION BASED ON PERSONAL PROFILES

2003228066-MESSAGE ROUTING IN A RADIO NETWORK